- Eloxx Pharmaceuticals Inc To Host Investor and Analyst Call on Alport Syndrome TranscriptJun 27, 2023
- Eloxx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 22, 2023
- Eloxx Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Eloxx Pharmaceuticals Inc Topline ELX-02 Phase 2 Combination Results Call TranscriptSep 14, 2022
- Eloxx Pharmaceuticals Inc Topline ELX-02 Phase 2 Results Call and Webcast TranscriptNov 17, 2021
- Eloxx Pharmaceuticals Inc Analyst Call on Cystic Fibrosis Programs TranscriptOct 12, 2021
- Eloxx Pharmaceuticals, Inc., Zikani Therapeutics, Inc. - M&A Call TranscriptApr 01, 2021
- Q4 2020 Eloxx Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2021$154.8 (+2.65%)Earnings
- Q3 2020 Eloxx Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$108.8 (+4.21%)Earnings
- Q2 2020 Eloxx Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$123.6 (-6.93%)Earnings
- Eloxx Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 20, 2020
- Q1 2020 Eloxx Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$116.4 (+14.12%)Earnings
- Q4 2019 Eloxx Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2020$138 (-9.92%)Earnings
- Eloxx Pharmaceuticals, Inc. - Special Call TranscriptJan 14, 2020
- Q3 2019 Eloxx Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$262 (-6.89%)Earnings
- Q2 2019 Eloxx Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019$242.8 (-9.40%)Earnings
- Q1 2019 Eloxx Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$474 (+7.63%)Earnings
- Eloxx Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Eloxx Pharmaceuticals Inc Earnings Call TranscriptMar 08, 2019$470.4 (+1.55%)Earnings
Eloxx Pharmaceuticals Inc Analyst Call on Cystic Fibrosis Programs Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Eloxx Pharmaceuticals conference call and webcast on cystic fibrosis programs. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, John Woolford. John, you may begin.
Thank you. Good morning, and thank you to everyone who has joined today's call to discuss Eloxx Pharmaceuticals' cystic fibrosis program. An audio archive of this conference call will be available on the Eloxx Pharmaceuticals' website in the Investor Relations section later today. Also, please note that there are slides to accompany today's event. These slides are available through the webcast. Joining me today are Sumit Aggarwal, President and CEO; Dr. Vijay Modur, Head of Research and Development. In addition, we are pleased to have Dr. Eitan Kerem, a globally renowned CF expert with us on the call today.
Before we begin with prepared remarks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)